With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?
When it rains, it pours, at least when it comes to effective coronavirus vaccines. With Moderna (NASDAQ: MRNA) joining Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) this week in the very exclusive club of companies with an effective and safe candidate, it's only a matter of time until the trio start to make money from vaccine sales, assuming they get regulatory approval to do so. In the meantime, there's a decision to make: Which stock will be the best investment?
In my view, it isn't a close call. Now that it has the clinical evidence it needs to validate the scientific approach at the core of its platform, Moderna is going to become a monster.
Image souce: Getty Images.
Source Fool.com
